Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DPLO

Diplomat Pharmacy (DPLO) Stock Price, News & Analysis

Diplomat Pharmacy logo

About Diplomat Pharmacy Stock (NYSE:DPLO)

Advanced Chart

Key Stats

Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DPLO Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Netflix's Hostage feels like The Diplomat lite
See More Headlines

DPLO Stock Analysis - Frequently Asked Questions

Diplomat Pharmacy Inc (NYSE:DPLO) announced its earnings results on Tuesday, November, 12th. The company reported ($2.35) earnings per share for the quarter, missing the consensus estimate of ($0.20) by $2.15. The company's quarterly revenue was down 5.3% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diplomat Pharmacy investors own include Bausch Health Cos (BHC), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Cara Therapeutics (CARA), Cannabis Sativa (CBDS), CVS Health (CVS) and Jazz Pharmaceuticals (JAZZ).

Company Calendar

Last Earnings
11/12/2019
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NYSE:DPLO
CIK
1610092
Fax
N/A
Employees
2,335
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.20
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$302.27 million
Net Margins
-12.47%
Pretax Margin
N/A
Return on Equity
-12.15%
Return on Assets
-3.05%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
0.55
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$5.49 billion
Price / Sales
0.06
Cash Flow
$4.60 per share
Price / Cash Flow
0.87
Book Value
$6.24 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
76,000,000
Free Float
N/A
Market Cap
$304 million
Optionable
Optionable
Beta
0.82
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:DPLO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners